Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Amgen Inc (AMGN)

Amgen Inc (AMGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 135,342,304
  • Shares Outstanding, K 533,579
  • Annual Sales, $ 25,979 M
  • Annual Income, $ 5,893 M
  • 60-Month Beta 0.67
  • Price/Sales 5.27
  • Price/Cash Flow 10.78
  • Price/Book 37.32
Trade AMGN with:

Options Overview Details

View History
  • Implied Volatility 25.08% ( +0.01%)
  • Historical Volatility 16.02%
  • IV Percentile 68%
  • IV Rank 54.88%
  • IV High 30.79% on 04/26/22
  • IV Low 18.13% on 08/16/22
  • Put/Call Vol Ratio 0.33
  • Today's Volume 7,220
  • Volume Avg (30-Day) 6,124
  • Put/Call OI Ratio 0.83
  • Today's Open Interest 88,534
  • Open Int (30-Day) 120,933

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 4.02
  • Number of Estimates 9
  • High Estimate 4.16
  • Low Estimate 3.83
  • Prior Year 4.36
  • Growth Rate Est. (year over year) -7.80%

Price Performance

See More
Period Period Low Period High Performance
1-Month
252.54 +0.44%
on 01/27/23
276.84 -8.38%
on 01/11/23
-9.74 (-3.70%)
since 12/27/22
3-Month
252.54 +0.44%
on 01/27/23
296.67 -14.50%
on 11/08/22
-13.58 (-5.08%)
since 10/27/22
52-Week
214.39 +18.31%
on 02/24/22
296.67 -14.50%
on 11/08/22
+29.65 (+13.24%)
since 01/27/22

Most Recent Stories

More News
3 Stocks That Could Make You a Millionaire in the Long Term

With economic growth moderating just enough to keep hopes of a Fed-engineered ‘soft landing’ alive, shares of fundamentally strong, resilient, and growing businesses AT&T (T), Amgen (AMGN), Humana...

AMGN : 253.65 (-0.48%)
HUM : 481.69 (-3.54%)
T : 19.95 (-0.25%)
Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know

Amgen (AMGN) closed the most recent trading day at $254.88, moving -0.65% from the previous trading session.

AMGN : 253.65 (-0.48%)
AMGEN ANNOUNCES WEBCAST OF 2022 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its fourth quarter and full year 2022 financial results on Tuesday, Jan. 31, 2023,...

AMGN : 253.65 (-0.48%)
Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks

The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income...

AMGN : 253.65 (-0.48%)
FCBC : 32.14 (-0.86%)
GLP : 35.85 (-1.89%)
2 Top Biotech Stocks to Buy for the Long Haul

Developing new products will be key to the success of both of these biotech leaders.

AMGN : 253.65 (-0.48%)
MRNA : 189.35 (-2.01%)
HORIZON THERAPEUTICS INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Horizon Therapeutics Public Limited Company - HZNP

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Horizon Therapeutics Public Limited Company...

HZNP : 110.63 (-0.56%)
AMGN : 253.65 (-0.48%)
Earnings Preview: GSK (GSK) Q4 Earnings Expected to Decline

Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GSK : 35.30 (-0.11%)
AMGN : 253.65 (-0.48%)
Amgen (AMGN) to Report Q4 Earnings: What's in the Cards?

Volume growth from Amgen's (AMGN) key drugs like Prolia, Otezla, Repatha and others is expected to have been partially offset by biosimilar/generic competition for mature drugs.

AZN : 65.53 (-0.70%)
MRK : 105.38 (-1.39%)
AMGN : 253.65 (-0.48%)
HZNP : 110.63 (-0.56%)
Should You Invest in the VanEck Biotech ETF (BBH)?

Sector ETF report for BBH

BBH : 169.07 (+0.02%)
AMGN : 253.65 (-0.48%)
GILD : 83.73 (+0.13%)
VRTX : 321.45 (+0.13%)
IBB : 137.23 (+0.05%)
XBI : 89.39 (+0.90%)
2 Top Passive-Income Stocks to Own in 2023

These dividend stocks can deliver both downside protection and capital appreciation.

AMGN : 253.65 (-0.48%)
ABBV : 146.28 (-0.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two...

See More

Key Turning Points

3rd Resistance Point 258.21
2nd Resistance Point 256.86
1st Resistance Point 255.25
Last Price 253.65
1st Support Level 252.29
2nd Support Level 250.94
3rd Support Level 249.33

See More

52-Week High 296.67
Fibonacci 61.8% 265.24
Fibonacci 50% 255.53
Last Price 253.65
Fibonacci 38.2% 245.82
52-Week Low 214.39

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar